Skip to main content
Log in

Modifying quinolone antibiotics yields new anxiolytics

  • Brief Communication
  • Published:

From Nature Medicine

View current issue Submit your manuscript

Abstract

Patients taking fluoroquinolone antibiotics such as norfloxacin exhibit a low incidence of convulsions and anxiety. These side effects probably result from antagonism of the neurotransmitter γ-aminobutyric acid (GABA) at the brain GABAA receptor complex (GRC). Modification of norfloxacin yields molecules such as compound 4 that potentiate GABA action with α2 subunit selectivity. Compound 4 is anxiolytic but does not cause sedation, and may represent a new class of ligands that have anxiolytic activity without sedative liability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Compound 4 modulates GABA-mediated currents in recombinant human GRCs.
Figure 2: Compound 4 is anxiolytic in rodent models of anxiety, without causing motor impairment.

Similar content being viewed by others

References

  1. Chebib, M. & Johnston, G.A. J. Med. Chem. 43, 1427–1447 (2000).

    Article  CAS  Google Scholar 

  2. Halliwell, R.F., Davey, P.G. & Lambert, J.J. J. Antimicrob. Chemother. 31, 457–462 (1993).

    Article  CAS  Google Scholar 

  3. Korpi, E.R., Grunder, G. & Luddens, H. Prog. Neurobiol. 67, 113–159 (2002).

    Article  CAS  Google Scholar 

  4. De Sarro, A. et al. Antimicrob. Agents Chemother. 43, 1729–1736 (1999).

    Article  CAS  Google Scholar 

  5. McKernan, R.M. et al. Nat. Neurosci. 3, 587–592 (2000).

    Article  CAS  Google Scholar 

  6. Vogel, J.R., Beer, B. & Clody, D.E. Psychopharmacologia (Berlin) 21, 1–7 (1971).

    Article  CAS  Google Scholar 

  7. Carboni, E., Wieland, S., Lan, N.C. & Gee, K.W. Psychopharmacology (Berlin) 126, 173–178 (1996).

    Article  CAS  Google Scholar 

  8. Crawley, J. & Goodwin, F.K. Pharmacol. Biochem. Behav. 13, 167–170 (1980).

    Article  CAS  Google Scholar 

  9. Wieland, S., Lan, N.C., Mirasedeghi, S. & Gee, K.W. Brain Res. 565, 263–268 (1991).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This research was supported by National Institute of Mental Health grant MH60527 (K.W.G.) and the Wellcome Trust (R.F.H.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kelvin W Gee.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Johnstone, T., Hogenkamp, D., Coyne, L. et al. Modifying quinolone antibiotics yields new anxiolytics. Nat Med 10, 31–32 (2004). https://doi.org/10.1038/nm967

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm967

  • Springer Nature America, Inc.

This article is cited by

Navigation